189 related articles for article (PubMed ID: 28895089)
21. Patient reported experiences following laparoscopic prophylactic bilateral salpingo-oophorectomy or salpingectomy in an ambulatory care hospital.
Trister R; Jacobson M; Nguyen P; Sobel M; Allen L; Narod SA; Kotsopoulos J
Fam Cancer; 2021 Apr; 20(2):103-110. PubMed ID: 32964297
[TBL] [Abstract][Full Text] [Related]
22. Salpingo-oophorectomy at the Time of Benign Hysterectomy: A Systematic Review.
Evans EC; Matteson KA; Orejuela FJ; Alperin M; Balk EM; El-Nashar S; Gleason JL; Grimes C; Jeppson P; Mathews C; Wheeler TL; Murphy M;
Obstet Gynecol; 2016 Sep; 128(3):476-85. PubMed ID: 27500347
[TBL] [Abstract][Full Text] [Related]
23. Postoperative Outcomes After Staged Versus Coordinated Breast Surgery and Bilateral Salpingo-Oophorectomy.
Vemuru SR; Bronsert M; Vossler K; Huynh VD; Beaty L; Ahrendt G; Arruda J; Kaoutzanis C; Rojas KE; Bozzuto L; Kim S; Tevis SE
Ann Surg Oncol; 2023 Sep; 30(9):5667-5680. PubMed ID: 37336806
[TBL] [Abstract][Full Text] [Related]
24. Use of hormone replacement therapy after risk-reducing salpingo-oophorectomy.
Johansen N; Liavaag AH; Iversen OE; Dørum A; Braaten T; Michelsen TM
Acta Obstet Gynecol Scand; 2017 May; 96(5):547-555. PubMed ID: 28236297
[TBL] [Abstract][Full Text] [Related]
25. Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients.
Grann VR; Panageas KS; Whang W; Antman KH; Neugut AI
J Clin Oncol; 1998 Mar; 16(3):979-85. PubMed ID: 9508180
[TBL] [Abstract][Full Text] [Related]
26. Ovarian function preservation with GnRH agonist in young breast cancer patients: does it impede the effect of adjuvant chemotherapy?
Kim J; Kim M; Lee JH; Lee H; Lee SK; Bae SY; Jun SY; Kil WH; Lee JE; Kim SW; Nam SJ
Breast; 2014 Oct; 23(5):670-5. PubMed ID: 25088482
[TBL] [Abstract][Full Text] [Related]
27. The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer--a population-based data linkage study.
Obermair A; Youlden DR; Baade PD; Janda M
Int J Cancer; 2014 May; 134(9):2211-22. PubMed ID: 24127248
[TBL] [Abstract][Full Text] [Related]
28. Incidence of ovarian cancer after bilateral salpingo-oophorectomy in women with histologically proven endometriosis.
Hermens M; van Altena AM; Bulten J; van Vliet HAAM; Siebers AG; Bekkers RLM
Fertil Steril; 2022 May; 117(5):938-945. PubMed ID: 35300832
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in hormone receptor-positive postmenopausal women with early-stage breast cancer.
Delea TE; Karnon J; Sofrygin O; Thomas SK; Papo NL; Barghout V
Clin Breast Cancer; 2007 Jun; 7(8):608-18. PubMed ID: 17592673
[TBL] [Abstract][Full Text] [Related]
30. Malignancies following bilateral salpingo-oophorectomy (BSO).
Gotlieb WH; Barchana M; Ben-Baruch G; Friedman E
Eur J Surg Oncol; 2006 Dec; 32(10):1231-4. PubMed ID: 16626923
[TBL] [Abstract][Full Text] [Related]
31. Ovarian ablation or suppression in premenopausal early breast cancer: results from the international adjuvant breast cancer ovarian ablation or suppression randomized trial.
Adjuvant Breast Cancer Trials Collaborative Group
J Natl Cancer Inst; 2007 Apr; 99(7):516-25. PubMed ID: 17405996
[TBL] [Abstract][Full Text] [Related]
32. Letrozole plus GnRH analogue as preoperative and adjuvant therapy in premenopausal women with ER positive locally advanced breast cancer.
Torrisi R; Bagnardi V; Rotmensz N; Scarano E; Iorfida M; Veronesi P; Luini A; Viale G; Santoro A; Colleoni M; Goldhirsch A
Breast Cancer Res Treat; 2011 Apr; 126(2):431-41. PubMed ID: 21221766
[TBL] [Abstract][Full Text] [Related]
33. Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations.
Schmeler KM; Sun CC; Bodurka DC; White KG; Soliman PT; Uyei AR; Erlichman JL; Arun BK; Daniels MS; Rimes SA; Peterson SK; Slomovitz BM; Milam MR; Gershenson DM; Lu KH
Obstet Gynecol; 2006 Sep; 108(3 Pt 1):515-20. PubMed ID: 16946209
[TBL] [Abstract][Full Text] [Related]
34. Concurrent uterine surgery and uptake of hormone therapy in patients undergoing bilateral salpingo-oophorectomy for risk-reducing or therapeutic indications.
Sasse SA; Lee SS; Rajeev P; Sharma SR; Kahan T; Pothuri B
Gynecol Oncol; 2023 Dec; 179():131-137. PubMed ID: 37988946
[TBL] [Abstract][Full Text] [Related]
35. The Cost-Effectiveness of Salpingectomies for Family Planning in the Prevention of Ovarian Cancer.
Tai RWM; Choi SKY; Coyte PC
J Obstet Gynaecol Can; 2018 Mar; 40(3):317-327. PubMed ID: 29054509
[TBL] [Abstract][Full Text] [Related]
36. High yield of oocytes without an increase in circulating estradiol levels in breast cancer patients treated with follicle-stimulating hormone and aromatase inhibitor in standard gonadotropin-releasing hormone analogue protocols.
Ben-Haroush A; Farhi J; Ben-Aharon I; Sapir O; Pinkas H; Fisch B
Isr Med Assoc J; 2011 Dec; 13(12):753-6. PubMed ID: 22332446
[TBL] [Abstract][Full Text] [Related]
37. What is the role of ovarian ablation in the management of primary and metastatic breast cancer today?
Prowell TM; Davidson NE
Oncologist; 2004; 9(5):507-17. PubMed ID: 15477635
[TBL] [Abstract][Full Text] [Related]
38. Ovarian preservation compared to oophorectomy in premenopausal women with early-stage, low-grade endometrial Cancer: A cost-effectiveness analysis.
Hernandez-Zepeda ML; Munro EG; Caughey AB; Bruegl AS
Gynecol Oncol; 2023 Jun; 173():8-14. PubMed ID: 37030073
[TBL] [Abstract][Full Text] [Related]
39. Assessing the Risk of Occult Cancer and 30-day Morbidity in Women Undergoing Risk-reducing Surgery: A Prospective Experience.
Bogani G; Tagliabue E; Signorelli M; Chiappa V; Carcangiu ML; Paolini B; Casarin J; Scaffa C; Gennaro M; Martinelli F; Borghi C; Ditto A; Lorusso D; Raspagliesi F
J Minim Invasive Gynecol; 2017; 24(5):837-842. PubMed ID: 28479170
[TBL] [Abstract][Full Text] [Related]
40. Management of hereditary breast and ovarian cancer.
Yamauchi H; Takei J
Int J Clin Oncol; 2018 Feb; 23(1):45-51. PubMed ID: 29185095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
